U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Facial hypertrichosis

MedGen UID:
342000
Concept ID:
C1851400
Finding
Synonym: Facial Hypertrichosis
 
HPO: HP:0002219
OMIM®: 134000

Definition

Excessive, increased hair growth located in the facial region. [from HPO]

Term Hierarchy

Conditions with this feature

Familial porphyria cutanea tarda
MedGen UID:
75669
Concept ID:
C0268323
Disease or Syndrome
Familial porphyria cutanea tarda (F-PCT) is characterized by: skin findings including blistering over the dorsal aspects of the hands and other sun-exposed areas of skin, skin friability after minor trauma, facial hypertrichosis and hyperpigmentation, and severe thickening of affected skin areas (pseudoscleroderma); and an increased risk for hepatocellular carcinoma (HCC).
Peters plus syndrome
MedGen UID:
163204
Concept ID:
C0796012
Disease or Syndrome
Peters plus syndrome is characterized by anterior chamber eye anomalies, short limbs with broad distal extremities, characteristic facial features, cleft lip/palate, and variable developmental delay / intellectual disability. The most common anterior chamber defect is Peters' anomaly, consisting of central corneal clouding, thinning of the posterior cornea, and iridocorneal adhesions. Cataracts and glaucoma are common. Developmental delay is observed in about 80% of children; intellectual disability can range from mild to severe.
Warburg micro syndrome 1
MedGen UID:
333142
Concept ID:
C1838625
Disease or Syndrome
RAB18 deficiency is the molecular deficit underlying both Warburg micro syndrome (characterized by eye, nervous system, and endocrine abnormalities) and Martsolf syndrome (characterized by similar – but milder – findings). To date Warburg micro syndrome comprises >96% of reported individuals with genetically defined RAB18 deficiency. The hallmark ophthalmologic findings are bilateral congenital cataracts, usually accompanied by microphthalmia, microcornea (diameter <10), and small atonic pupils. Poor vision despite early cataract surgery likely results from progressive optic atrophy and cortical visual impairment. Individuals with Warburg micro syndrome have severe to profound intellectual disability (ID); those with Martsolf syndrome have mild to moderate ID. Some individuals with RAB18 deficiency also have epilepsy. In Warburg micro syndrome, a progressive ascending spastic paraplegia typically begins with spastic diplegia and contractures during the first year, followed by upper-limb involvement leading to spastic quadriplegia after about age five years, often eventually causing breathing difficulties. In Martsolf syndrome infantile hypotonia is followed primarily by slowly progressive lower-limb spasticity. Hypogonadism – when present – manifests in both syndromes, in males as micropenis and/or cryptorchidism and in females as hypoplastic labia minora, clitoral hypoplasia, and small introitus.
Rubinstein-Taybi syndrome due to 16p13.3 microdeletion
MedGen UID:
350477
Concept ID:
C1864648
Disease or Syndrome
Chromosome 16p13.3deletion syndrome is a chromosome abnormality that can affect many parts of the body. People with this condition are missing a small piece (deletion) of chromosome 16 at a location designated p13.3. Although once thought to be a severe form of Rubinstein-Taybi syndrome, it is now emerging as a unique syndrome. Signs and symptoms may include failure to thrive, hypotonia (reduced muscle tone), short stature, microcephaly (unusually small head), characteristic facial features, mild to moderate intellectual disability, organ anomalies (i.e. heart and/or kidney problems), and vulnerability to infections. Chromosome testing of both parents can provide information about whether the deletion was inherited. In most cases, parents do not have any chromosome abnormalities. However, sometimes one parent has a balanced translocation where a piece of a chromosome has broken off and attached to another one with no gain or loss of genetic material. The balanced translocation normally does not cause signs or symptoms, but it increases the risk for having a child with a chromosome abnormality like a deletion. Treatment is based on the signs and symptoms present in each person.To learn more about chromosome abnormalities in general, view our GARD fact sheet on Chromosome Disorders.
Coffin-Siris syndrome 1
MedGen UID:
482831
Concept ID:
C3281201
Disease or Syndrome
Coffin-Siris syndrome (CSS) is classically characterized by aplasia or hypoplasia of the distal phalanx or nail of the fifth and additional digits, developmental or cognitive delay of varying degree, distinctive facial features, hypotonia, hirsutism/hypertrichosis, and sparse scalp hair. Congenital anomalies can include malformations of the cardiac, gastrointestinal, genitourinary, and/or central nervous systems. Other findings commonly include feeding difficulties, slow growth, ophthalmologic abnormalities, and hearing impairment.
Rubinstein-Taybi syndrome due to CREBBP mutations
MedGen UID:
1639327
Concept ID:
C4551859
Disease or Syndrome
Rubinstein-Taybi syndrome (RSTS) is characterized by distinctive facial features, broad and often angulated thumbs and halluces, short stature, and moderate-to-severe intellectual disability. The characteristic craniofacial features are downslanted palpebral fissures, low-hanging columella, high palate, grimacing smile, and talon cusps. Prenatal growth is often normal, then height, weight, and head circumference percentiles rapidly drop in the first few months of life. Short stature is typical in adulthood. Obesity may develop in childhood or adolescence. Average IQ ranges between 35 and 50; however, developmental outcome varies considerably. Some individuals with EP300-RSTS have normal intellect. Additional features include ocular abnormalities, hearing loss, respiratory difficulties, congenital heart defects, renal abnormalities, cryptorchidism, feeding problems, recurrent infections, and severe constipation.
Zimmermann-laband syndrome 3
MedGen UID:
1684740
Concept ID:
C5231447
Disease or Syndrome
Zimmermann-Laband syndrome-3 (ZLS3) is characterized by developmental delay, intellectual disability, coarse face, gingival hyperplasia, and nail hypoplasia/aplasia (Bauer et al., 2019). For a general phenotypic description and a discussion of genetic heterogeneity of Zimmermann-Laband syndrome, see ZLS1 (135500).

Professional guidelines

PubMed

Osio A, Mateus C, Soria JC, Massard C, Malka D, Boige V, Besse B, Robert C
Br J Dermatol 2009 Sep;161(3):515-21. Epub 2009 Apr 10 doi: 10.1111/j.1365-2133.2009.09214.x. PMID: 19466958
Verdich J
Dermatologica 1984;168(2):87-9. doi: 10.1159/000249674. PMID: 6698269

Recent clinical studies

Etiology

Bergfeld W, Washenik K, Callender V, Zhang P, Quiza C, Doshi U, Blume-Peytavi U
J Drugs Dermatol 2016 Jul 1;15(7):874-81. PMID: 27391639
Muñoz-Santos C, Guilabert A, Moreno N, To-Figueras J, Badenas C, Darwich E, Herrero C
Medicine (Baltimore) 2010 Mar;89(2):69-74. doi: 10.1097/MD.0b013e3181d50928. PMID: 20517178
Osio A, Mateus C, Soria JC, Massard C, Malka D, Boige V, Besse B, Robert C
Br J Dermatol 2009 Sep;161(3):515-21. Epub 2009 Apr 10 doi: 10.1111/j.1365-2133.2009.09214.x. PMID: 19466958
Raulin C, Greve B
Eur J Dermatol 2000 Mar;10(2):103-6. PMID: 10694307

Diagnosis

Alexandris D, Alevizopoulos N, Palamaris K, Gakiopoulou C, Theocharis S
J Oncol Pharm Pract 2023 Apr;29(3):731-737. Epub 2022 Jul 12 doi: 10.1177/10781552221114073. PMID: 35821579
de Souza LC, Sgardioli IC, Gil-da-Silva-Lopes VL, Vieira TP
Am J Med Genet A 2018 Aug;176(8):1753-1759. Epub 2018 Jul 28 doi: 10.1002/ajmg.a.38842. PMID: 30055032
Ehmke N, Graul-Neumann L, Smorag L, Koenig R, Segebrecht L, Magoulas P, Scaglia F, Kilic E, Hennig AF, Adolphs N, Saha N, Fauler B, Kalscheuer VM, Hennig F, Altmüller J, Netzer C, Thiele H, Nürnberg P, Yigit G, Jäger M, Hecht J, Krüger U, Mielke T, Krawitz PM, Horn D, Schuelke M, Mundlos S, Bacino CA, Bonnen PE, Wollnik B, Fischer-Zirnsak B, Kornak U
Am J Hum Genet 2017 Nov 2;101(5):833-843. doi: 10.1016/j.ajhg.2017.09.016. PMID: 29100093Free PMC Article
Muñoz-Santos C, Guilabert A, Moreno N, To-Figueras J, Badenas C, Darwich E, Herrero C
Medicine (Baltimore) 2010 Mar;89(2):69-74. doi: 10.1097/MD.0b013e3181d50928. PMID: 20517178
Biolcati G, Dolazza C
Int J Dermatol 2006 Aug;45(8):976-8. doi: 10.1111/j.1365-4632.2006.02931.x. PMID: 16911388

Therapy

Alexandris D, Alevizopoulos N, Palamaris K, Gakiopoulou C, Theocharis S
J Oncol Pharm Pract 2023 Apr;29(3):731-737. Epub 2022 Jul 12 doi: 10.1177/10781552221114073. PMID: 35821579
Benmously Mlika R, Ben Hamida M, Hammami H, Dorbani Ben Thabet I, Rouatbi M, Mokhtar I
J Cosmet Laser Ther 2013 Aug;15(4):217-8. Epub 2013 Mar 6 doi: 10.3109/14764172.2013.764434. PMID: 23463948
Raulin C, Greve B
Eur J Dermatol 2000 Mar;10(2):103-6. PMID: 10694307
Manzione NC, Wolkoff AW, Sassa S
Gastroenterology 1988 Oct;95(4):1119-22. doi: 10.1016/0016-5085(88)90191-6. PMID: 3410226
Lapidus SM
J Surg Oncol 1976;8(3):267-74. doi: 10.1002/jso.2930080314. PMID: 778495

Prognosis

Raulin C, Greve B
Eur J Dermatol 2000 Mar;10(2):103-6. PMID: 10694307
Manzione NC, Wolkoff AW, Sassa S
Gastroenterology 1988 Oct;95(4):1119-22. doi: 10.1016/0016-5085(88)90191-6. PMID: 3410226

Clinical prediction guides

Ehmke N, Graul-Neumann L, Smorag L, Koenig R, Segebrecht L, Magoulas P, Scaglia F, Kilic E, Hennig AF, Adolphs N, Saha N, Fauler B, Kalscheuer VM, Hennig F, Altmüller J, Netzer C, Thiele H, Nürnberg P, Yigit G, Jäger M, Hecht J, Krüger U, Mielke T, Krawitz PM, Horn D, Schuelke M, Mundlos S, Bacino CA, Bonnen PE, Wollnik B, Fischer-Zirnsak B, Kornak U
Am J Hum Genet 2017 Nov 2;101(5):833-843. doi: 10.1016/j.ajhg.2017.09.016. PMID: 29100093Free PMC Article
Low KJ, Ansari M, Abou Jamra R, Clarke A, El Chehadeh S, FitzPatrick DR, Greenslade M, Henderson A, Hurst J, Keller K, Kuentz P, Prescott T, Roessler F, Selmer KK, Schneider MC, Stewart F, Tatton-Brown K, Thevenon J, Vigeland MD, Vogt J, Willems M, Zonana J, Study DD, Smithson SF
Eur J Hum Genet 2017 May;25(5):552-559. Epub 2017 Mar 22 doi: 10.1038/ejhg.2017.27. PMID: 28327570Free PMC Article
Bergfeld W, Washenik K, Callender V, Zhang P, Quiza C, Doshi U, Blume-Peytavi U
J Drugs Dermatol 2016 Jul 1;15(7):874-81. PMID: 27391639
Biolcati G, Dolazza C
Int J Dermatol 2006 Aug;45(8):976-8. doi: 10.1111/j.1365-4632.2006.02931.x. PMID: 16911388
Danforth RA, Melrose RJ, Abrams AM, Handlers JP
Oral Surg Oral Med Oral Pathol 1990 Jul;70(1):81-5. doi: 10.1016/0030-4220(90)90183-s. PMID: 2371053

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...